Cough and Cold Medicine Market 2028 By Type, Formulation, End User and Geography | The Insight Partners

report image

Cough and Cold Medicine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Others); Formulation (Oral Syrups, Tablets, Nasal Drops, Others); End User (Hospitals, Clinics, Others) and Geography

Report Code: TIPRE00017802 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Cold medications used by people with the common cold, cough, or related conditions. The common cold spread from person to person through various mediums such as cough droplets, sneezes, and mucus in hand. Common factors that cause colds include seasonal factors, close contact with an infected person, smoking and exposure to cigarette smoke, weak immune system, and various chronic illness such as diabetes, autoimmune diseases, and asthma. The common cause of cold and cough is a respiratory tract infection, such as a cold or flu. Respiratory tract infections are usually caused by a virus and may last from a few days to a week. Infections caused by the flu may take a little longer to clear up and can sometimes require antibiotics.


The cough and cold medicine market has shown a significant evolution over the forecast period. The rise of the cough and cold medicine market is majorly driven by the increasing rate of self-medication among patients and the availability of over-the-counter (OTC) drugs. According to the study, 'Self-medication with over the counter drugs, the prevalence of the risky practice and its associated factors in pharmacy outlets of Asmara, Eritrea,' published in February 2019, in the journal BMC Public Health, 93.7% of the survey participants practiced self-medication with OTC drugs. The most commonly preferred drug groups are analgesics, followed by antipyretics and cough and cold preparations. Moreover, increasing the development and launch of generic drugs is also expected to aid in the market's growth. Furthermore, the emergence of a new coronavirus is also likely to assist in developing the market. However, recall and failure of cold and cough remedies are expected to impede the market's growth. For instance, in March 2019, DG Health issued a recall for its DG/health Naturals baby Cough Syrup + Mucus due to bacterial contamination.


The "Cough and Cold Medicine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, with a specific focus on the global market trend analysis. This report provides an outline of the cough and cold medicine market with detailed market segmentation by type, formulation, and end-user. The cough and cold medicine market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the cough and cold medicine market and offers key opportunities and trends in the market.


The market is categorized based on the type, formulation, and end user. Based on the type, the market is segmented as antihistamines, expectorants, bronchodilators, decongestants, and others. Based on the formulation, the segmentation of the market is into oral syrups, tablets, nasal drops, and others. Based on end user, segmentation of the market is into hospitals, clinics, and others.


The report states a comprehensive outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the cough and cold medicine market based on various segments. The report also comprises market size and forecast estimates from the year 2020 to2028with respect to five primary regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East, and Africa (MEA), and South & Central America (SCAM). The Cough and cold medicine market by each region are then sub-segmented into respective countries and segments. It provides the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the cough and cold medicine market from both the demand and supply sides. Moreover, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after assessing political, social, economic, and technological factors affecting the Cough and cold medicine market in these regions.

Get more information on this report :


The report contains critical developments in the cough and cold medicine market as inorganic and organic growth strategies. Multiple companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Many such activities have paved the path for the elaboration of the business and customer base of market players. The market players from the Cough and cold medicine market are estimated to have profitable growth opportunities in the coming years with the higher demand for cough and cold medicine in the global market. Mentioned below is the list of a few companies engaged in the Cough and cold medicine market.

The report also provides key players' profiles in the cough and cold medicine market, along with their SWOT analysis and market strategies. Moreover, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

  •  Pfizer Inc.
  •  Atley Pharmaceuticals, Inc.
  •  Novartis International AG
  •  Merck & Co., Inc.
  •  Johnson & Johnson Services, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  AstraZeneca
  •  Sanofi
  •  Sun Pharmaceutical Industries Ltd.
  •  Mankind Pharma Ltd.

The Insight Partner's dedicated research and the analytical team consists of experienced professionals with advanced statistical expertise and provides various customization options in the current study.

Get more information on this report :

1. Pfizer Inc.
2. Atley Pharmaceuticals, Inc.
3. Novartis International AG
4. Merck & Co., Inc.
5. Johnson & Johnson Services, Inc.
6. F. Hoffmann-La Roche Ltd
7. AstraZeneca
8. Sanofi
9. Sun Pharmaceutical Industries Ltd.
10. Mankind Pharma Ltd.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount